Drawing for CVS

USPTO serial 98874080

CVS

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
MMEJE, OBIEZE GINIKANWA
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with CVS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,844*

Plus Government fees of $900

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erich G. Rhynhart

One CVS DriveMailcode: 1160Woonsocket, RI 02895

Goods and services

ClassDescriptionStatusFirst use
003Teeth whitening kits; teeth whitening strips impregnated with teeth whitening preparations; teeth whitening pens sold filled with teeth whitening preparations; household cleaning preparations, namely, aligner and retainer cleaners; non-medicated mouthwashes; non-medicated toothpaste; breath freshening sprays; breath freshening strips; cleaning tablets for dentures; denture cleaning preparations; shower steamers in the nature of bath meltsACTIVE—
005A full line of medicines, remedies and preparations, namely, acetaminophen, ibuprofen, aspirin, diclofenac sodium for pain relief, headache treatment preparations, caffeine preparations for stimulative use, combinations of aspirin and caffeine for pain relief, naproxen sodium for pain relief, motion sickness treatment preparations; urinary pain relief preparations; menstrual pain relief preparations; sleep aid preparations; pain relief medications; preparations for the relief of pain; creams, lotions, and muscle-rub preparations for the relief of pain; vitamin preparations; vitamin supplements; Nasal spray preparations and nasal cleaning preparations for medical purposes in mist form; Saline solution for sinus and nasal irrigation; Saline solution for medical purposes; Nasal rinse; Decongestant nasal strips; Cough treatment preparations; Cough treatment preparations in the nature of cough suppressants and cough syrups; Throat lozenges; Cold and flu treatment preparations; Dietary supplements for immunity support, sleep support and digestive health; Cold sore treatment preparations; Powdered dietary supplement drink mix for immunity support; Medicated topical analgesic; Medicated throat spray; Allergy relief medication; Eye drops; Ear drops; Hydrocortisone cream; Laxatives; Laxative suppositories; Antacids; Electrolyte drinks for medical purposes; dietary effervescent tablet supplements for immunity support; Probiotic supplements; Anti-itch creams and ointments; Medicinal creams and ointments for the treatment of colds, flu, headache, and allergy symptoms; Menthol for pharmaceutical purposes, namely, menthol vapor lotion, menthol ointments, and menthol pads; Diarrhea medication; hemorrhoid treatment preparations; dietary fiber supplements; dietary fiber to aid digestion; bismuth preparations for medical purposes; enzyme preparations for medical purposes; gastro-intestinal treatment preparations; anti-gas medications; enema preparations; medicinal preparations, namely, acid reflux, ulcer, and heartburn relief preparations; motion sickness treatment preparations; dietary and nutritional supplements containing berberine; dietary and nutritional supplements to aid digestion; stool softeners; Oral analgesics; oral antiseptics; tooth filling repair kits; medicated toothpaste; medicated mouthwashes; dental wax; dietary supplement to treat dry mouth; dental adhesivesACTIVE—
009Magnifying glasses; mouthguards for athletic useACTIVE—
010Pill and tablet cutters and crushers; Massaging apparatus for personal use; dosage dispensers for administering medicine, including, spoons, droppers, and syringes; blood pressure monitors; medical devices, namely, nose speculum, tongue depressor, oral mirrors and scalers for dental care, ear speculum and diagnostic penlights for medical purposes; nasal aspirators; bulb syringes for medical use; ear plugs for sleeping; Thermometers for medical use; Thermometer strips for medical use; Fever thermometers; Ear thermometers; Sinus and nasal inhalers for medical purposes, sold empty; Neti pots; Cooling patches for medical purposes; Enema syringes; enema apparatus for medical purposes; Teeth protectors for dental purposes; mouth guards for medical purposes; vaporizers for medical purposesACTIVE—
011HumidifiersACTIVE—
021Pill organizers for personal use; Medication containers for personal use; Toothbrushes; electric toothbrushes; electric toothbrush replacement heads; dental floss; dental floss picks; interdental brushes and dental floss picks for cleaning teeth; tongue cleaning devices, namely, tongue cleaning brushesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 12, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 11, 2026EX2GSOU EXTENSION 2 GRANTED—
Jun 11, 2026EXT2SOU EXTENSION 2 FILED—
Jun 11, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 18, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 18, 2025EX1GSOU EXTENSION 1 GRANTED—
Dec 18, 2025EXT1SOU EXTENSION 1 FILED—
Dec 18, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 15, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 20, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 20, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 14, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 22, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 22, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 22, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 22, 2025ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 17, 2025GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 17, 2025GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 17, 2025CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 4, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 4, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 4, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 8, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2025DOCKASSIGNED TO EXAMINER—
Dec 24, 2024MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 24, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 26, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance